Literature DB >> 6743836

Impaired natural killer cell function in hemophiliacs with or without continuous substitution.

F Porzsolt, M Hauser, C Piper, S Scholz, H Stötter, G Pindur, E Seifried, H Rasche.   

Abstract

In the present study, 28 hemophiliacs substituted continuously and 5 hemophiliacs who had received almost no blood products were investigated. Cells of OKT 3+, OKT 4+, and OKT 8+ subsets were counted. Percoll separated fractions of peripheral blood mononuclear cells were examined by morphological criteria and were tested for NK cell activity. We found that the NK cell activity of both groups of hemophiliacs was decreased on testing Ficoll separated cells or low density Percoll separated cells. Normal NK cell activity was found in medium density cells of hemophiliacs. Two possible explanations are discussed: first, the NK cell activity may be suppressed in hemophiliacs and secondly, there may be a block in maturation of NK cell activity. It is unlikely that chronic substitution by blood products counts for these alterations. The possible role of chronic infections is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6743836     DOI: 10.1007/BF00320385

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  17 in total

1.  Pseudo-AIDS.

Authors:  D A Walker; J S Lilleyman
Journal:  Lancet       Date:  1983-08-06       Impact factor: 79.321

2.  Impaired cell-mediated immunity in patients with classic hemophilia.

Authors:  M M Lederman; O D Ratnoff; J J Scillian; P K Jones; B Schacter
Journal:  N Engl J Med       Date:  1983-01-13       Impact factor: 91.245

3.  T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.

Authors:  J E Menitove; R H Aster; J T Casper; S J Lauer; J L Gottschall; J E Williams; J C Gill; D V Wheeler; V Piaskowski; P Kirchner; R R Montgomery
Journal:  N Engl J Med       Date:  1983-01-13       Impact factor: 91.245

4.  Epidemiologic aspects of the current outbreak of Kaposi's sarcoma and opportunistic infections.

Authors: 
Journal:  N Engl J Med       Date:  1982-01-28       Impact factor: 91.245

5.  Update on Kaposi's sarcoma and opportunistic infections in previously healthy persons--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1982-06-11       Impact factor: 17.586

6.  Disseminated Kaposi's sarcoma in homosexual men.

Authors:  A E Friedman-Kien; L J Laubenstein; P Rubinstein; E Buimovici-Klein; M Marmor; R Stahl; I Spigland; K S Kim; S Zolla-Pazner
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

7.  Opportunistic infections and immune deficiency in homosexual men.

Authors:  D Mildvan; U Mathur; R W Enlow; P L Romain; R J Winchester; C Colp; H Singman; B R Adelsberg; I Spigland
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

8.  Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation.

Authors:  J A Levy; J L Ziegler
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

9.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.

Authors:  M S Gottlieb; R Schroff; H M Schanker; J D Weisman; P T Fan; R A Wolf; A Saxon
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

10.  Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions.

Authors:  F P Siegal; C Lopez; G S Hammer; A E Brown; S J Kornfeld; J Gold; J Hassett; S Z Hirschman; C Cunningham-Rundles; B R Adelsberg
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

View more
  4 in total

1.  Lymphocyte autoantibodies and alloantibodies in HIV-positive haemophilia patients.

Authors:  V Daniel; K Schimpf; G Opelz
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

2.  Defective postbinding lysis underlies the impaired natural killer activity in factor VIII-treated, human T lymphotropic virus type III seropositive hemophiliacs.

Authors:  M Katzman; M M Lederman
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

3.  Deficient IFN alpha production in hairy cell leukemia.

Authors:  F Porzsolt; R Janik; G Heil; O Brudler; A Raghavachar; S Scholz; U Papendick; H Heimpel
Journal:  Blut       Date:  1986-03

4.  HTLV III antibodies and immunological alterations in hemophilia patients.

Authors:  E Seifried; G Pindur; H Stötter; F Porzsolt; H Rasche; V Erfle; R Hehlmann; H Heimpel
Journal:  Klin Wochenschr       Date:  1986-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.